Aligned Genetics, Inc. (KOSDAQ:238120)

Aligned Genetics Revenue

Aligned Genetics had revenue of 3.64B KRW in the quarter ending March 31, 2026, a decrease of -7.16%. This brings the company's revenue in the last twelve months to 15.73B, down -4.69% year-over-year. In the year 2025, Aligned Genetics had annual revenue of 16.02B with 1.51% growth.

• Revenue (ttm): 15.73B
• Revenue Growth: -4.69%
• P/S Ratio: 3.04
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 47.80B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	16.02B	238.34M	1.51%
Dec 31, 2024	15.78B	562.88M	3.70%
Dec 31, 2023	15.21B	1.46B	10.63%
Dec 31, 2022	13.75B	1.99B	16.92%
Dec 31, 2021	11.76B	3.80B	47.82%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 25, 2026

Data Sources Report a data error